Document is current
Any future updates will be listed below
-
Authors
Bliss, Judith M.
Tovey, Holly
Evans, Abigail
Holcombe, Chris
Horgan, Kieran
Mallon, Elizabeth
Vidya, Raghavan
Skene, Anthony
Dodson, Andrew
Hills, Margaret
Detre, Simone
Zabaglo, Lila
Banerji, Jane
Kilburn, Lucy
Morden, James P.
Robertson, John F. R.
Smith, Ian
Dowsett, Mitch
,
- License Information
-
More Information
Article History
Received: 2 December 2022
Accepted: 27 February 2023
First Online: 12 April 2023
Declarations
:
: POETIC was approved by the London South-East Research Ethics Committee (reference number 08/H1102/37). All patients provided written informed consent. The Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, UK (ICR-CTSU), had overall responsibility for trial and data management.
: Not applicable.
: JMB reports grants from Cancer Research UK, during the conduct of the study; grants from Medivation; grants and non-financial support from AstraZeneca, Merck Sharp & Dohme, Puma Biotechnology, Clovis Oncology, Pfizer, Janssen-Cilag, Novartis, and Roche, outside the submitted work. LK reports grants from Cancer Research UK, during the conduct of the study. MD reports grants from Cancer Research UK, during the conduct of the study; and personal fees from Radius, Roche, Myriad, Orion, G1 Therapeutics, Nanostring, AbbVie, H3 Biomedicine, Lilly, and the ICR Rewards for Inventors Scheme, outside the submitted work. All other authors declare no competing interests.
